Pharmacological management of fragile X syndrome: a systematic review and narrative summary of the current evidence

Lance V. Watkinsa Epilepsy Specialist Service, Swansea Bay University Health Board, Cardiff, UK;b Unit for Development in Intellectual and Developmental Disabilities, University of South Wales, Pontypridd, UK;c Cornwall Intellectual Disability Equitable Research (CIDER), University of Plymouth Peninsula School of Medicine, Truro, UKView further author information

Seungyoun Moona Epilepsy Specialist Service, Swansea Bay University Health Board, Cardiff, UKView further author information

Lisa Burrowsc Cornwall Intellectual Disability Equitable Research (CIDER), University of Plymouth Peninsula School of Medicine, Truro, UK;d Adult Neurodevelopmental Psychiatry, Cornwall Partnership NHS Trust, Truro, UKView further author information

Samuel Tromanse Department of Population Health Sciences, University of Leicester, Leicester, UK;f Adult Learning Disability Service, Leicestershire Partnership NHS Trust, Leicester, UKView further author information

Julian Barwellg Clinical Genetics Department, University Hospitals of Leicester, Leicester, UKView further author information

Rohit Shankarc Cornwall Intellectual Disability Equitable Research (CIDER), University of Plymouth Peninsula School of Medicine, Truro, UKCorrespondence[email protected]
View further author information

Pharmacological management of fragile X syndrome: a systematic review and narrative summary of the current evidence

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Pharmacological management of fragile X syndrome: a systematic review and narrative summary of the current evidence

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date